These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Hepatic Steatosis but Not Fibrosis Is Independently Associated with Poor Outcomes in Patients with Inflammatory Bowel Disease. Hyun HK; Lee HW; Park J; Park SJ; Park JJ; Kim TI; Lee JS; Kim BK; Park JY; Kim DY; Ahn SH; Kim SU; Cheon JH Gut Liver; 2024 Mar; 18(2):294-304. PubMed ID: 37203442 [TBL] [Abstract][Full Text] [Related]
17. Clinical Features Focusing on Extraintestinal Manifestations in Japanese Patients with Inflammatory Bowel Diseases: Far East 1000. Ohta Y; Taida T; Kato J; Ogasawara S; Oyama Y; Mamiya Y; Nakazawa H; Horio R; Goto C; Takahashi S; Kurosugi A; Sonoda M; Shiratori W; Kaneko T; Yokoyama Y; Akizue N; Ishigami H; Koseki H; Okimoto K; Saito K; Saito M; Matsumura T; Nakagawa T; Masuya Y; Fukuda Y; Kitsukawa Y; Shimura H; Tsuyuguchi T; Kato N Digestion; 2023; 104(4):328-334. PubMed ID: 36893744 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of inflammatory bowel disease in the Australian general practice population: A cross-sectional study. Busingye D; Pollack A; Chidwick K PLoS One; 2021; 16(5):e0252458. PubMed ID: 34043730 [TBL] [Abstract][Full Text] [Related]
19. Multifaceted pathogenesis of liver steatosis in inflammatory bowel disease: a systematic review. Spagnuolo R; Abenavoli L; Corea A; Larussa T; Mancina RM; Cosco C; Luzza F; Doldo P Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5818-5825. PubMed ID: 34604973 [TBL] [Abstract][Full Text] [Related]